A Unique Class of Duocarmycin and CC-1065 Analogues Subject to Reductive Activation
- 17 November 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 129 (49), 15391-15397
- https://doi.org/10.1021/ja075398e
Abstract
N-Acyl O-amino phenol derivatives of CBI-TMI and CBI-indole2 are reported as prototypical members of a new class of reductively activated prodrugs of the duocarmycin and CC-1065 class of antitumor agents. The expectation being that hypoxic tumor environments, with their higher reducing capacity, carry an intrinsic higher concentration of “reducing” nucleophiles (e.g., thiols) capable of activating such derivatives (tunable N−O bond cleavage) and increasing their sensitivity to the prodrug treatment. Preliminary studies indicate the prodrugs effectively release the free drug in functional cellular assays for cytotoxic activity approaching or matching the activity of the free drug, yet remain essentially stable and unreactive to in vitro DNA alkylation conditions (t1/2 = 3 h). Characterization of a representative O-(acylamino) prodrug in vivo indicates that they approach the potency and exceed the efficacy of the free drug itself (CBI-indole2), indicating that not only is the free drug effectively released from the inactive prodrug but also that they offer additional advantages related to a controlled or targeted release in vivo.This publication has 105 references indexed in Scilit:
- Asymmetric Total Synthesis of (+)- and ent-(−)-Yatakemycin and Duocarmycin SA: Evaluation of Yatakemycin Key Partial Structures and Its Unnatural EnantiomerJournal of the American Chemical Society, 2006
- Alkylation of duplex DNA in nucleosome core particles by duocarmycin SA and yatakemycinNature Chemical Biology, 2006
- Synthesis and Evaluation of Duocarmycin and CC-1065 Analogues Incorporating the 1,2,9,9a-Tetrahydrocyclopropa[c]benz[e]-3-azaindol-4-one (CBA) Alkylation SubunitThe Journal of Organic Chemistry, 2003
- Synthesis and cytotoxicity evaluation of novel C7–C7, C7–N3 and N3–N3 dimers of 1-chloromethyl-5-hydroxy-1,2-dihydro-3H-benzo[e]indole (seco-CBI) with pyrrole and imidazole polyamide conjugatesOrganic & Biomolecular Chemistry, 2003
- A 2-nitroimidazole carbamate prodrug of 5-amino-1-(chloromethyl)-3-[(5,6,7-trimethoxyindol-2-yl)carbonyl]-1,2-dihydro-3H-benz[e]indole (amino-seco-CBI-TMI) for use with ADEPT and GDEPTBioorganic & Medicinal Chemistry Letters, 1999
- Synthesis and Antitumor Activity of Duocarmycin Derivatives: Modification of Segment A of Duocarmycin B2.CHEMICAL & PHARMACEUTICAL BULLETIN, 1996
- Duocarmycins, Potent Antitumor Antibiotics Produced by Streptomyces sp. Structures and Chemistry.CHEMICAL & PHARMACEUTICAL BULLETIN, 1995
- Synthesis and Antitumor Activity of Duocarmycin Derivatives.CHEMICAL & PHARMACEUTICAL BULLETIN, 1995
- A potent, simple derivative of an analog of the CC-1065 alkylation subunitBioorganic & Medicinal Chemistry Letters, 1991
- Synthesis and preliminary evaluation of (+)-CBI-indole2: an enhanced functional analog of (+)-CC-1065Bioorganic & Medicinal Chemistry Letters, 1991